Bupropion/Mecamylamine

安非他酮/美加明

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBupropion/Mecamylamine
Drug Alias NameMecamylamine/Bupropion安非他酮+美加明Mecamylamine+Bupropion美加明+安非他酮美加明/安非他酮 +[10] 
ClassificationSmall molecules
Mechanisms of ActionAcetylcholine receptor; alpha1/beta1/delta/gamma antagonistsDopamine reuptake inhibitorsAdrenergic receptors antagonists
TargetsAcetylcholine receptor; alpha1/beta1/delta/gammaDopamine transporterAdrenergic receptors
Therapy Area/IndicationsTobacco Use Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Mecamylamine HydrochlorideBupropion Hydrochloride
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCary Pharmaceuticals
China Registration ClassN/A

Develop Information

Active CompaniesCary Pharmaceuticals
Inactive CompaniesN/A
Active IndicationsTobacco Use Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A